Lucid Diagnostics (LUCD) EPS (Basic) Growth (3y) (2023 - 2026)
Analysis
Lucid Diagnostics (LUCD) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.12 Bn | 46.02 Bn | 486.15 Mn | 21.74% |
| 2 | Labcorp Holdings | 26.25 Bn | 26.10 Bn | 1.11 Bn | 19.75% |
| 3 | Quest Diagnostics | 26.02 Bn | 25.40 Bn | 1.03 Bn | 10.55% |
| 4 | Guardant Health | 21.89 Bn | 20.84 Bn | 219.03 Mn | -10.58% |
| 5 | Tempus AI | 11.21 Bn | 10.39 Bn | 274.25 Mn | 26.92% |
| 6 | Caris Life Sciences | 6.94 Bn | 6.14 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.22 Bn | 4.86 Bn | 177.96 Mn | 30.89% |
| 8 | BillionToOne | 4.75 Bn | 4.20 Bn | 77.11 Mn | - |
| 9 | iRhythm Holdings | 3.98 Bn | 3.39 Bn | 163.21 Mn | 73.26% |
| 10 | Lucid Diagnostics | 153.93 Mn | 120.53 Mn | 55,000.00 | 33.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.40% |
| Mar 31, 2026 | 24.80% |
| Dec 31, 2025 | 27.10% |
| Sep 30, 2025 | 37.52% |
| Jun 30, 2025 | 42.03% |
| Mar 31, 2025 | -14.44% |
| Dec 31, 2024 | 27.83% |
| Sep 30, 2024 | 20.72% |
| Jun 30, 2024 | 19.44% |
| Mar 31, 2024 | -15.84% |
| Dec 31, 2023 | -10.26% |
| Sep 30, 2023 | -33.32% |